The clinical trial of 2,368 diabetes patients with cardiovascular disease, reported no increased rate of heart attack or death in patients taking rosiglitazone.

In fact, this analysis found a lower combined rate of death, heart attack and stroke associated with patients taking rosiglitazone compared with those who were not taking a thiazolidinedione drug (rosiglitazone or pioglitazone).

The international consortium of scientists, led by Professor Mark McCarthy of the University of Oxford, report their findings in the journal Nature Genetics ??“ 10 years after the first draft of the human genome was announced on 26 June 2000.???

The signals we have identified provide important clues to the biological basis of type 2 diabetes,??™ says Professor McCarthy of the Wellcome Trust Centre for Human Genetics at Oxford University. ???The challenge will be to turn these genetic findings into better ways of treating and preventing the condition.??™

A recent study, Diabetes in sub-Saharan Africa, led by the University of Yaound?© in Cameroon and published in the British medical journal, The Lancet, said inadequate donor attention and national prevention programmes were creating a global ???public health and socioeconomic time bomb???.

Diabetes is caused by inherited genetic factors and lifestyle choices, and manifests when the body does not produce enough insulin, or cannot break down sugar in the blood, according to the World Health Organisation. 

All this is a diabetic, anyway? A healthy food pyramid diet is the focus of diabetics. Diabetic recipes for a cookbook with diabetes driving and health prediabetics in their quest for a healthy food pyramid diet. The Centers for Disease Control and Prevention (CDC) estimates that in 2007, 23.6 million people in the United States have diabetes. This correct ponds 8% of the population. In addition, 5.7 million Meenjoy with diabetes do not even know. Therefore, if after a diabetes diet is important.

If you??™re wondering what it looks like a diabetic, it??™s a food pyramid for diabetics on the website of the American Diabetes Association. The diabetes food pyramid is easily accessible from the USDA Food Guide Pyramid.

The similarity in benefit comes with 2 important advantages ??” less weight gain and less hypoglycemia, said Daniel L. Lorber, MD, director of endocrinology and associate director of the Theresa and Eugene Lang Center for Research and Education at New York Hospital, in Queens.

Oral antidiabetes drugs can provide glycemic control early on in type 2 diabetes, but progressive beta-cell insufficiency can eventually lead to the need for insulin to lower blood sugar levels and achieve glycemic control, Dr. Lorber said. However, the use of insulin is often a delayed strategy because it is associated with weight gain, hypoglycemia, and the need for subcutaneous injections.

People with Type 2 diabetes who adhere to intensive blood sugar control, compared with standard blood sugar control, have reduced progression of retinopathy. In addition, patients treated with a combination of a cholesterol-lowering statin and fibrate drugs also had a lower rate of progression compared with patients taking statins alone. The study also concluded that intensive blood pressure control provided no other benefits compared with standard blood pressure control.

The data come from the ACCORD study, a landmark clinical trial of more than 10,000 adults with Type 2 diabetes who were at high risk of heart attack, stroke or death.

The paper is entitled, Effectiveness of Sensor-Augmented Insulin-Pump therapy in Type 1 Diabetes.

???Combining the best technologies for insulin delivery and blood sugar monitoring really pays off for diabetes control,??? says Dr. Bruce Perkins, one of the co-authors of the study, endocrinologist at Toronto General Hospital and Assistant Professor at the University of Toronto. ???Being aware of continuous blood sugar trends and having the tools to do something about them can help committed patients of all ages self-manage their diabetes very well.???

The consortium of researchers from across Europe, the United States and Canada said their findings would not only improve understanding of what lies behind type 2 diabetes, but suggest new biological processes that can be explored as possible targets for new medicines.

“The signals we have identified provide important clues to the biological basis of type 2 diabetes. The challenge will be to turn these genetic findings into better ways of treating and preventing the condition,” said Mark McCarthy of the centre for human genetics at Oxford University, who led the study, published Sunday in the journal Nature Genetics. 

The number grows each year. As more is learned about the genetic reasons why our bodies lose the ability to control sugar levels in the blood, we have a lot of catching up to do in regard to translating this knowledge into better individualized treatment plans in the doctor??™s office.

The rate of medical treatment failure for Type 2 diabetes is simply too high. While the diabetic ultimately is responsible for following the treatment plan, the choice of prescribed drug therapy often can be one size fits all. Failure may not always be the patient??™s fault, because many of the underlying causes which triggered the diabetes also might affect the response to treatment.

And the top drug prescribed to insured Utahns is anti-depressants, with depression another disease that is driving up health care costs.

The data is part of the Utah Department of Health??™s All-Payer Database, a collection of medical and pharmacy claims from commercial insurance companies. Patients??™ names are removed, but replaced by a unique identifier so their care can be tracked.

“Cognitive decline should be assessed and monitored in middle-aged people with type 2 diabetes,” write Astrid C.J. Nooyens, PhD, and colleagues, of the Centre for Prevention and Health Services Research, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.

The study was published online June 2 in Diabetes Care.

The study, conducted by the Institute for Clinical Evaluative Sciences, examined Canadian population trends to determine how to best prepare for a surge in diabetes cases. It concluded that about one out of every 10 adult Canadians—about 1.9 million people—will develop the disease within the next 10 years, and that public health authorities should start preparing for the glut now.

Dr. Douglas Manuel, the study’s lead author and a senior researcher with the Ottawa Hospital Research Institute, said people who are overweight (those with a body mass index—a measure of body fat based on height and weight—of between 25 and 29) and obese (BMI greater than 30) will make up half of all new diabetes diagnoses.

Diabetes, primarily type 2, doubles the risk of liver, pancreatic, and endometrial cancer. It also increases the risk of colorectal, breast and bladder cancer by 20 to 50%. An expert consensus panel of the American Diabetes Association (ADA) and the American Cancer Society (ACS) met to try to understand why and has written a statement published online in the journal Cancer.

???The full biologic link between diabetes and cancer has not been completely defined,??? says panel member Susan M. Gapstur PhD who is the ACS vice president of epidemiology. But there are some clues.

But over the past 11 years, Frances has been able to avoid diabetes, and her sugars are now normal. By participating in a ground-breaking, government-funded study, she learned how to make exercise and a healthy diet an integral part of her life, avoiding the insulin injections and heart and kidney problems that plagued her parents when they were in their 50’s.

“At first it was hard, but I took it as a religious (type of) thing,” she said recently. “If I hadn’t done this, I’d be a diabetic for sure.”

The diabetes care devices market in BRIC nations was approximately $257.55 million in 2009 and is expected to grow a CAGR of 17.24% from 2009 to 2014, driven mainly by the increasing incidence of diabetes and the corresponding rise in governmental support for diabetes care across BRIC nations. China was the largest diabetes care market in 2009 with approximately $135.65 million, followed for Russia, India, and Brazil.

Market estimates and forecast ; The report provides in-depth market estimates and forecast for diabetes care devices in Brazil, Russia, India and China. It includes estimates and forecast for insulin pumps, self monitoring blood glucose (SMBG) and continuous glucose monitoring (CGM) in each of the four geographies of Brazil, Russia, India and China.